Nelfinavir in Systemic Lupus Erythematosus

NCT02066311 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Nelfinavir

Sponsor

Northwell Health

Collaborators

[object Object]